(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-4-[(2S,4R,5S,6S)-4,5-二羟基-4,6-二甲基-氧杂环己烷-2-基]氧基-6-[(2S,3R,4S,6R)-4-二甲氨基-3-羟基-6-m乙基-氧杂环己烷-2-基]氧基-14-乙基-7,12,13-三羟基-3,5,7,9,11,13-六甲基-1-氧杂环十四烷-2,10-二酮(CAS 1675-02-1):分子式 C36H65NO13、分子量 719.9。
| CAS号 | 1675-02-1 |
|---|---|
| 分子式 | C36H65NO13 |
| 分子量 | 719.9 |
| LogP | 2.2 |
(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-4-[(2S,4R,5S,6S)-4,5-二羟基-4,6-二甲基-氧杂环己烷-2-基]氧基-6-[(2S,3R,4S,6R)-4-二甲氨基-3-羟基-6-m乙基-氧杂环己烷-2-基]氧基-14-乙基-7,12,13-三羟基-3,5,7,9,11,13-六甲基-1-氧杂环十四烷-2,10-二酮 是一种化工化合物,登记 CAS 号为 1675-02-1,分子式 C36H65NO13(分子量 719.9)。
登记 CAS 号:1675-02-1
其分子式 C36H65NO13 由 36 个碳、65 个氢、1 个氮、13 个氧 组成。
别名/同义词:(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-4-[(2S,4R,5S,6S)-4,5-二羟基-4,6-二甲基-氧杂环己烷-2-基]氧基-6-[(2S,3R,4S,6R)-4-二甲氨基-3-羟基-6-m乙基-氧杂环己烷-2-基]氧基-14-乙基-7,12,13-三羟基-3,5,7,9,11,13-六甲基-1-氧杂环十四烷-2,10-二酮 · (3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-4-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6 -dimethyl-oxan-2-yl]oxy-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-m ethyl-oxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexameth yl-1-oxacyclotetradecane-2,10-dione
(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-4-[(2S,4R,5S,6S)-4,5-二羟基-4,6-二甲基-氧杂环己烷-2-基]氧基-6-[(2S,3R,4S,6R)-4-二甲氨基-3-羟基-6-m乙基-氧杂环己烷-2-基]氧基-14-乙基-7,12,13-三羟基-3,5,7,9,11,13-六甲基-1-氧杂环十四烷-2,10-二酮 的 CAS 登记号为 1675-02-1。
分子式 C36H65NO13,分子量 719.9。
别名/同义词:(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-4-[(2S,4R,5S,6S)-4,5-二羟基-4,6-二甲基-氧杂环己烷-2-基]氧基-6-[(2S,3R,4S,6R)-4-二甲氨基-3-羟基-6-m乙基-氧杂环己烷-2-基]氧基-14-乙基-7,12,13-三羟基-3,5,7,9,11,13-六甲基-1-氧杂环十四烷-2,10-二酮、(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-4-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6 -dimethyl-oxan-2-yl]oxy-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-m ethyl-oxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexameth yl-1-oxacyclotetradecane-2,10-dione。
(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-4-[(2S,4R,5S,6S)-4,5-二羟基-4,6-二甲基-氧杂环己烷-2-基]氧基-6-[(2S,3R,4S,6R)-4-二甲氨基-3-羟基-6-m乙基-氧杂环己烷-2-基]氧基-14-乙基-7,12,13-三羟基-3,5,7,9,11,13-六甲基-1-氧杂环十四烷-2,10-二酮(CAS 1675-02-1)的独立参考数据,整理自公开化学数据库。
| CAS Registry Number | 1675-02-1 |
|---|---|
| PubChem CID | 83933 |
| Molecular formula | C36H65NO13 |
| IUPAC name | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione |
| UNII (FDA) | 9X2R375YNZ |
| Molecular Weight | 719.9 |
|---|---|
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 6 |
| Exact Mass | 719.44559113 |
| Monoisotopic Mass | 719.44559113 |
| Topological Polar Surface Area | 205 |
| Heavy Atom Count | 50 |
Erythromycin C; 1675-02-1; Erythromycin, 3''-O-demethyl-; 9X2R375YNZ; CHEBI:64273; DTXSID501317437; RefChem:137784; DTXCID201747249; (3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-4-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6 -dimethyl-oxan-2-yl]oxy-6-[(2; Erythromycin C RS; Erythromycin C CRS; UNII-9X2R375YNZ; orb1692321; SCHEMBL1348180; MWFRKHPRXPSWNT-QNPWSHAKSA-N; MFCD22666225
(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-4-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6 -dimethyl-oxan-2-yl]oxy-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-m ethyl-oxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexameth yl-1-oxacyclotetradecane-2,10-dione · CAS 1675-02-1 · C36H65NO13. UNII 9X2R375YNZ.
数据来源:PubChem / Wikidata;与随货 COA 不一致时以 COA 为准。